Live Breaking News & Updates on S multiple sclerosis

Stay informed with the latest breaking news from S multiple sclerosis on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in S multiple sclerosis and stay connected to the pulse of your community

British Societies Develop First 'Living' Behçet Guidelines

The British Society for Rheumatology and the British Association of Dermatologists developed guidelines for the management of people living with Behçet's disease.

United-kingdom , British , Tony-thornburn , British-society-for-rheumatology , National-health-service , Foundation-trust-in-liverpool , European-alliance-of-associations , British-association-of-dermatologists , University-of-liverpool , Liverpool-university-hospitals , British-society , British-association

Vaccine Safety and DMT for Highly Active MS: New Data

Many clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.

Spain , Emory-university , Georgia , United-states , Atlanta , Barcelona , Comunidad-autonoma-de-cataluna , Hebron , Israel-general- , Israel , Universitari-vall , John-cunningham

ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data

There is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are taking checkpoint inhibitor therapy, results of a small study suggest.

Massachusetts , United-states , Boston , Jordan , American , Prashanth-rajarajan , Department-of-neurology , Harvard-medical-school , American-academy-of-neurology , Medscape-medical , American-academy , Medscape-medical-news

Multiple Sclerosis and Epstein-Barr Virus: What Do We Know?

Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?

Germany , German , Bruce-bebo , Natalia-drosu , Stanford-university-lawrence-steinman , Neurological-sciences , National-ms-society , Harvard-medical-school , Biomedical-engineering-center , National-institute-of-allergy , Medscape-medical-news , Public-health

Better Outcomes With Early HETs in Pediatric-Onset MS

Early initiation of HET in pediatric-onset MS was linked to slower progression to disability compared to treatment with low-efficacy therapy or no treatment.

Toronto , Ontario , Canada , Melbourne , Victoria , Australia , Italy , Italian , Sifat-sharman , E-ann-yeh , Department-of-medicine , University-of-melbourne

Common Household Chemicals Tied to Brain Cell Damage

Two classes of pervasive environmental chemicals that are present in household cleaners, furniture and electronics had "surprising" effects specifically on the non-nerve cells in the brain.

Ohio , United-states , Florida , Miami , New-york , Cleveland , Sarah-evans , Shaheen-lakhan , Paul-tesar , Nutrition-examination , Department-of-environmental-medicine , Case-western-reserve-university-school-of-medicine

US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis

The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis...

Bengaluru , Karnataka , India , United-states , Pooja-desai , Shinjini-ganguli , Sriparna-roy , Mapi-pharma , Reuters , National-institutes-of-health , Teva-pharmaceutical-industrie , National-institutes

First-Line Highly Effective Therapy Better for Pediatric MS

New research supports the use of highly effective therapies as first-line treatment in children with relapsing-remitting pediatric-onset multiple sclerosis.

France , Department-of-pediatric-neurology , University-angers , Expanded-disability-status-scale , Nail-benallegue , Pediatric-neurology , Multiple-sclerosis-ms , S-multiple-sclerosis , Children , Hild , Hildhood

Emerging Therapies Foretell New Era for Cutaneous Disorders

Analogous to the early 2000s when treatment options for psoriasis jumped, the same may be true now for treating cutaneous autoimmune disorders.

United-states , France , Ohio , Cleveland , American , Anthony-fernandez , Astrazeneca , Drug-administration , American-academy-of-dermatology , Pfizer , Cleveland-clinic , Cutaneous-lupus-erythematosus-disease-area

Off-Label Gabapentin Use Up Despite 'Dearth of Evidence'

The drug may be prescribed with sedating medications even after a 2019 warning from the FDA about such combinations.

Michigan , United-states , Ann-arbor , Michaele-johansen , Donovant-maust , Expenditure-panel , Drug-administration , Ann-arbor-va-center , National-institute-on-drug-abuse , Clinical-management-research , University-of-michigan